Fein Seymour Howard
SEC insider (Form 3/4/5 filer). CIK 0002147180. CRO/CMO at Oncotelic Therapeutics, Inc. (OTLC). 1 reported Form 4/5 transaction since Sep 2024; latest on Jul 10, 2026. Located in AGOURA HILLS, CA.
Companies Fein Seymour Howard has filed insider reports for
- Oncotelic Therapeutics, Inc. (OTLC): Officer, CRO/CMO
Fein Seymour Howard
CIK: 0002147180
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OTLC
Oncotelic Therapeutics, Inc.
Officer